Cargando…

Survivin siRNA对人肺腺癌细胞SPCA1和SH77抑制作用的比较分析

BACKGROUND AND OBJECTIVE: Survivin, a member of the inhibitor of apoptosis (IAP) protein family, has been demonstrated as a potential new target for apoptosis-based therapy in cancer and lymphoma. The aim of this study is to investigate effects and mechanisms of survivin siRNA transfection on lung a...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999702/
https://www.ncbi.nlm.nih.gov/pubmed/21219826
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.01.04
_version_ 1783331483650359296
collection PubMed
description BACKGROUND AND OBJECTIVE: Survivin, a member of the inhibitor of apoptosis (IAP) protein family, has been demonstrated as a potential new target for apoptosis-based therapy in cancer and lymphoma. The aim of this study is to investigate effects and mechanisms of survivin siRNA transfection on lung adenocarcinoma cell lines SPCA1 and SH77. METHODS: A siRNA plasmid expression vector and pSi scrambled against survivin were constructed and transfected into SPCA1 and SH77 cells with Lipofectamine 2000. The proliferations of lung adenocarcinoma SPCA1 and SH77 cells were detected by MTT. The apoptotic rate and cell cycle were detected by flow cytometer. The activity of survivin mRNA and protein expression were analyzed with RT-PCR and Western blot. RESULTS: Survivin siRNA reduced the proliferation of SPCA1 and SH77 cells. Cell cycle was inhibited in G(0)/G(1). Expressions of survivin siRNA mRNA and protein were reduced in transfected cells compared with the control cells. CONCLUSION: siRNA targeted against survivin can effectively suppress SPCA1 and SH77 cells proliferation and significantly induce SPCA1 and SH77 cells apoptosis.
format Online
Article
Text
id pubmed-5999702
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59997022018-07-06 Survivin siRNA对人肺腺癌细胞SPCA1和SH77抑制作用的比较分析 Zhongguo Fei Ai Za Zhi 基础研究 BACKGROUND AND OBJECTIVE: Survivin, a member of the inhibitor of apoptosis (IAP) protein family, has been demonstrated as a potential new target for apoptosis-based therapy in cancer and lymphoma. The aim of this study is to investigate effects and mechanisms of survivin siRNA transfection on lung adenocarcinoma cell lines SPCA1 and SH77. METHODS: A siRNA plasmid expression vector and pSi scrambled against survivin were constructed and transfected into SPCA1 and SH77 cells with Lipofectamine 2000. The proliferations of lung adenocarcinoma SPCA1 and SH77 cells were detected by MTT. The apoptotic rate and cell cycle were detected by flow cytometer. The activity of survivin mRNA and protein expression were analyzed with RT-PCR and Western blot. RESULTS: Survivin siRNA reduced the proliferation of SPCA1 and SH77 cells. Cell cycle was inhibited in G(0)/G(1). Expressions of survivin siRNA mRNA and protein were reduced in transfected cells compared with the control cells. CONCLUSION: siRNA targeted against survivin can effectively suppress SPCA1 and SH77 cells proliferation and significantly induce SPCA1 and SH77 cells apoptosis. 中国肺癌杂志编辑部 2011-01-20 /pmc/articles/PMC5999702/ /pubmed/21219826 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.01.04 Text en 版权所有©《中国肺癌杂志》编辑部2011 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 基础研究
Survivin siRNA对人肺腺癌细胞SPCA1和SH77抑制作用的比较分析
title Survivin siRNA对人肺腺癌细胞SPCA1和SH77抑制作用的比较分析
title_full Survivin siRNA对人肺腺癌细胞SPCA1和SH77抑制作用的比较分析
title_fullStr Survivin siRNA对人肺腺癌细胞SPCA1和SH77抑制作用的比较分析
title_full_unstemmed Survivin siRNA对人肺腺癌细胞SPCA1和SH77抑制作用的比较分析
title_short Survivin siRNA对人肺腺癌细胞SPCA1和SH77抑制作用的比较分析
title_sort survivin sirna对人肺腺癌细胞spca1和sh77抑制作用的比较分析
topic 基础研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999702/
https://www.ncbi.nlm.nih.gov/pubmed/21219826
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.01.04
work_keys_str_mv AT survivinsirnaduìrénfèixiànáixìbāospca1hésh77yìzhìzuòyòngdebǐjiàofēnxī
AT survivinsirnaduìrénfèixiànáixìbāospca1hésh77yìzhìzuòyòngdebǐjiàofēnxī
AT survivinsirnaduìrénfèixiànáixìbāospca1hésh77yìzhìzuòyòngdebǐjiàofēnxī
AT survivinsirnaduìrénfèixiànáixìbāospca1hésh77yìzhìzuòyòngdebǐjiàofēnxī
AT survivinsirnaduìrénfèixiànáixìbāospca1hésh77yìzhìzuòyòngdebǐjiàofēnxī
AT survivinsirnaduìrénfèixiànáixìbāospca1hésh77yìzhìzuòyòngdebǐjiàofēnxī